Eli Lilly & Co. will pay $18.5 million to end Mississippi’s case against it for
promotional claims related to the anti-psychotic drug Zyprexa, according to an announcement made by state Attorney General Jim Hood at the end of January.
Applied Biosystems LLC, part of Life
Technologies Corp., and Idaho Technology Inc. announced in late January that they signed a cross-licensing agreement that covers a broad range of products,
including hardware, software and reagents
Two interesting events followed my February commentary, “Cleveland: The next biotech hub?” First, readers
began to contact me to show support for my argument that with some effort and organization, multi-challenged Cleveland could become the next Research
As a key part of its plan to expand its global operations and supply chain to achieve increased efficiencies in production, Watson
Pharmaceuticals Inc. recently completed the acquisition of Eden Biopharm Group
Weeks after rumors began to circulate that
Ranbaxy was in talks to buy a vaccine company, the Indian pharma announced in late January that it has acquired certain assets of Biovel Life Sciences
Private Ltd., a biotechnology firm focused on the manufacturing of biogenerics, biosuperiors and biopharmaceuticals based in Bangalore, India.
It doesn’t take a very elegant sensor to detect the current general malaise. Those of us who are old enough to have suffered a
half-dozen such cycles know that we’ve come out of them by focusing on and delivering on innovation.